A research consortium funded by the EU with ~12 Million € has been launched.
The project entitled “Targets and biomarkers for antiepileptogenesis” (EPITARGET)
is focused on identifying novel biomarkers for epileptogenesis and exploring new ways of how to treat epilepsy.
The project brings together 18 partners from 10 different European countries,
amongst the SFB 1089 PIs A. Becker, S. Schoch, F. Mormann and H. Beck